Home » Medical Devices » Ventricular Assist Devices Market

Ventricular Assist Devices Market By Type (Right Ventricular Assist Devices, Left Ventricular Assist Devices, Bi-Ventricular Assist Devices), By Application (Bridge To Transplant (BTT), Bridge To Destination (BTD), Bridge To Recovery (BTR) ), – Growth, Share, Opportunities & Competitive Analysis, 2017 – 2025

Price: $4999

Published: | Report ID: 11726 | Report Format : PDF

Market Insights:

Congestive heart failure is a potentially life-threatening condition that weakens the heart muscles and reduces the ability to pump blood through the body. Patients’ lives can be extended and improved with the use of ventricular assist devices, which are an effective alternative to a heart transplant. Ventricular assist devices are mechanical instruments that improve the pumping of blood and maintain the efficient flow throughout the body. The rising number of geriatric patients with cardiac complications, lifestyle changes with increasing consumption of junk food and binge drinking, and drug abuse are responsible for the rise in lifestyle diseases like cardiovascular disease, diabetes, and stroke. An increasing number of cardiovascular surgical procedures will result in deep market penetration for ventricular assist devices.

For the purpose of this study, the various types studied include a left ventricular assist device, a right ventricular assist device, and a biventricular assist device. The ventricular assist device applications are further categorized as “bridge to transplant,” “bridge to destination,” and “bridge to recovery.” Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

The global ventricular assist device market is segmented geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa markets. The regions are also further sub-segmented on the basis of a cross-sectional study by device, application, and major countries. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global ventricular assist devices market. Competition assessment tools such as Porter’s five forces analysis, market attractiveness assessment, and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the global ventricular assist devices market. The key players profiled in this report are Abiomed, Berlin Heart GmbH, Cardiac Assist, Inc., HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., St. Jude Medical, LLC, Sun Medical Technology Research Corp., Syncardia System, Inc., and Thoratec Corporation.

Based on type, the global ventricular assist devices market is categorized into:

  • Left Ventricular Assist Devices
  • Right Ventricular Assist Devices
  • Bi-Ventricular Assist Devices

A ventricular assist device is a mechanical pump that takes blood from the lower chamber of the heart and pumps it to the body and vital organs. They are used for a short duration in patients recovering from myocardial infarction or cardiac surgery, whereas long-term use is for patients suffering from total heart failure and patients suffering from class III and IV heart failure waiting for a heart transplant. The rise in lifestyle diseases like cardiomyopathy, diabetes, and stroke, higher efficacy, better patient suitability, and easy availability at low cost are fueling the ventricular assist devices market’s growth. In 2016, left ventricular assist devices held the largest market share due to the rising number of patients suffering from left ventricular damage, i.e., cardiomyopathy, and the reduction in the number of heart donors.

The right ventricular assist devices segment is anticipated to register faster growth throughout the forecast period of 2017–2025, primarily due to the increasing number of patients suffering from congestive heart failure and pulmonary hypertension. Overall, the global ventricular assist devices market is highly competitive, with multiple players specializing in respective fields, such as Thoratec, Abiomed, St. Jude Medical, LLC, Reliant Heart, Inc., HeartWare International, Inc., SynCardia System, Inc., and others. Since the first generation of devices with pulsatile volume displacement pump powered by pneumatic or electrical drive systems, which were later replaced by the second generation continuous flow pumps, technological advancement in device design, raw materials, and manufacturing has been significant.

Based on application areas, the global ventricular assist devices market is categorized into:

  • Bridge to Transplant (BTT)
  • Bridge to Destination (BTD)
  • Bridge to Recovery (BTR)

According to the European Society of Cardiology (ESC), 17%–45% of heart failure patients admitted to hospitals worldwide die within one year of admission. The British Heart Foundation (BHF) claims that the causative agents for heart failure are heart valve problems, abuse of alcohol or recreational drugs, arrhythmia, congenital heart disease, a viral infection of the heart muscles, etc. In 2016, the bridge-to-transplant segment dominated the application market significantly due to factors such as the rising prevalence of congestive heart failure and the increasing number of patients who showed failure in optimal medical management, were at risk of imminent death and required immediate heart transplantation.

The bridge-to-destination segment will be the fastest growing segment in the application market throughout the forecast period of 2017–2025, primarily due to factors such as the large number of patients who are deemed too old for a heart transplant, have compromised immunity, have a left ventricular ejection fraction less than 25%, and can survive with an LVAD throughout their lifespan. Bridge to recovery offers lucrative market opportunities as it is finding huge applications in patients with temporary heart failure. Patients recovering from heart surgery get VADs implanted until the heart is strong enough to pump blood.

For the purpose of this study, the global ventricular assist devices market is categorized into the following regional and country-specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

In the base year 2016, North America was observed to be the largest market for ventricular assist devices. According to the Centers for Disease Control and Prevention, about 610,000 Americans die each year due to heart disease, which represents 1 in every four deaths. The dominance of North America is mainly attributed to the rise in lifestyle diseases such as cardiovascular disease, stroke, and chronic pulmonary hypertension; a shift in lifestyle with increased drug abuse, binge drinking, and fast food consumption; and an evolved reimbursement scenario favoring the use of ventricular assist devices. According to the European Cardiovascular Disease Statistics for 2017, each year, CVD causes 3.9 million deaths in Europe and 1.8 million deaths in the European Union.

The market growth in Europe is chiefly attributed to the increasing number of patients suffering from cardiovascular complications and supportive regulatory approval for the ventricular assist devices market. Asia Pacific will be the fastest-growing regional segment throughout the forecast period of 2017–2025. Factors that propel market growth are the rising prevalence of geriatric populations suffering from cardiac complications, increasing healthcare expenditure in these regions, and increasing disposable incomes. Factors such as developing health infrastructure, increasing awareness, and increasing demand for ventricular assist devices are going to fuel the rapid growth of the ventricular assist devices market in Latin America, the Middle East, and Africa in the near future.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Ventricular Assist Devices Market Portraiture
2.1.1. Global Ventricular Assist Devices Market, by Type, 2016
2.1.2. Global Ventricular Assist Devices Market, by Application, 2016
2.1.3. Global Ventricular Assist Devices Market, by Geography, 2016

Chapter 3. Ventricular Assist Devices Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Prevalence Data of Major Target Diseases (Coronary Artery Disease, Cardiomyopathy)
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Porter’s Five Forces Analysis
3.7. Attractive Investment Proposition, by Geography
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Ventricular Assist Devices Market, by Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Ventricular Assist Devices Market, by Type
4.3. Right Ventricular Assist Devices
4.4. Left Ventricular Assist Devices
4.5. Bi-Ventricular Assist Devices

Chapter 5. Global Ventricular Assist Devices Market, by Application, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Attractive Investment Proposition: Global Ventricular Assist Devices Market, by Application
5.3. Bridge to Transplant (BTT)
5.4. Bridge to Destination (BTD)
5.5. Bridge to Recovery (BTR)

Chapter 6. Global Ventricular Assist Devices Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Ventricular Assist Devices Market Analysis, 2015 – 2025
6.2.1. North America Ventricular Assist Devices Market, by Type, 2015 – 2025 (US$ Mn)
6.2.2. North America Ventricular Assist Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.2.3. North America Ventricular Assist Devices Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Ventricular Assist Devices Market Analysis, 2015 – 2025
6.3.1. Europe Ventricular Assist Devices Market, by Type, 2015 – 2025 (US$ Mn)
6.3.2. Europe Ventricular Assist Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.3.3. Europe Ventricular Assist Devices Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. France
6.3.3.4. Rest of Europe
6.4. Asia Pacific Ventricular Assist Devices Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Ventricular Assist Devices Market, by Type, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Ventricular Assist Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Ventricular Assist Devices Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of APAC
6.5. Latin America Ventricular Assist Devices Market Analysis, 2015 – 2025
6.5.1. Latin America Ventricular Assist Devices Market, by Type, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Ventricular Assist Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Ventricular Assist Devices Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Ventricular Assist Devices Market Analysis, 2015 – 2025
6.6.1. MEA Ventricular Assist Devices Market, by Type, 2015 – 2025 (US$ Mn)
6.6.2. MEA Ventricular Assist Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.6.3. MEA Ventricular Assist Devices Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Abiomed
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Berlin Heart GmbH
7.3. Cardiac Assist, Inc.
7.4. HeartWare International, Inc.
7.5. Jarvik Heart, Inc.
7.6. Reliant Heart, Inc.
7.7. St. Jude Medical, LLC.
7.8. Sun Medical Technology Research Corp.
7.9. Syncardia System, Inc.
7.10. Thoratec Corporation

 

List of Figures

FIG. 1 Ventricular Assist Devices: Market Segmentation
FIG. 2 Global Ventricular Assist Devices Market Share, by Type, 2016 (Value %)
FIG. 3 Global Ventricular Assist Devices Market Share, by Application, 2016 (Value %)
FIG. 4 Global Ventricular Assist Devices Market Share, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Left Ventricular Assist Devices Market, by Type 2015 – 2025 (US$ Mn)
FIG. 8 Global Right Ventricular Assist Devices Market, by Type 2015 – 2025 (US$ Mn)
FIG. 9 Global Bi-Ventricular Assist Devices Market, by Type 2015 – 2025 (US$ Mn)
FIG. 10 Global Ventricular Assist Devices Market as Bridge to Transplant, 2015 – 2025 (US$ Mn)
FIG. 11 Global Ventricular Assist Devices Market as Bridge to Destination, 2015 – 2025 (US$ Mn)
FIG. 12 Global Ventricular Assist Devices Market as Bridge to Recovery, 2015 – 2025 (US$ Mn)
FIG. 13 U.S. Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)
FIG. 14 Canada Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)
FIG. 15 U.K. Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)
FIG. 16 Germany Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)
FIG. 17 France Ventricular Assist Devices Market, 2015-2025 (US$ Mn)
FIG. 18 Rest of Europe Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)
FIG. 19 Japan Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)
FIG. 20 China Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)
FIG. 21 India Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest of Asia Pacific Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)
FIG. 23 Brazil Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)
FIG. 24 Mexico Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest of Latin America Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)
FIG. 26 GCC Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)
FIG. 27 Rest of Middle East and Africa Ventricular Assist Devices Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Ventricular Assist Devices Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Ventricular Assist Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 3 Global Ventricular Assist Devices Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Ventricular Assist Devices Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Ventricular Assist Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 6 North America Ventricular Assist Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Ventricular Assist Devices Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Ventricular Assist Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Ventricular Assist Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Asia Pacific Ventricular Assist Devices Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Ventricular Assist Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Ventricular Assist Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Latin America Ventricular Assist Devices Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Ventricular Assist Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America Ventricular Assist Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 16 Middle East and Africa Ventricular Assist Devices Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 17 Middle East and Africa Ventricular Assist Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 18 Middle East and Africa Ventricular Assist Devices Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 19 Abiomed: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Berlin Heart GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Cardiac Assist, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 HeartWare International, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Jarvik Heart, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Reliant Heart, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 St. Jude Medical, LLC.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Sun Medical Technology Research Corp.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Syncardia System, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Thoratec Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Frequently Asked Questions:

What is the size of Ventricular Assist Devices Market?

The market for Ventricular Assist Devices Market is expected to reach US$ 2,323.41 Mn By 2025.

What is the Ventricular Assist Devices Market CAGR?

The Ventricular Assist Devices Market is expected to see significant CAGR growth over the coming years, at 8.85%.

What is the Forecast period considered for Ventricular Assist Devices Market?

The report is forecasted from 2017-2025.

What is the base year considered for Ventricular Assist Devices Market?

The base year of this report is 2015.

Who are the major players in this market?

Abiomed, Berlin Heart GmbH, Cardiac Assist, Inc., HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., St. Jude Medical, LLC, Sun Medical Technology Research Corp., Syncardia System, are some of the major players in the global market.

CSF (Cerebrospinal Fluid) Management Market

Published:
Report ID: 12389

Hypodermic Needles Market

Published:
Report ID: 6174

Implantable Infusion Pumps Market

Published:
Report ID: 12455

Medical Robots Market

Published:
Report ID: 42360

Magnetic Resonance Imaging (MRI) Systems Market

Published:
Report ID: 7815

Medical Device Technologies Market

Published:
Report ID: 42130

Transfection Reagents Market

Published:
Report ID: 41609

Intracranial Stents Market

Published:
Report ID: 7131

Hot And Cold Therapy Packs Market

Published:
Report ID: 7187

Digital Therapeutics Market

Published:
Report ID: 5029

Needles Market

Published:
Report ID: 41010

Microbial Contract Biomanufacturing Market

Published:
Report ID: 41008

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN